Loading…
Decoy Therapeutics Inc. is projected to decline to $5.07 by 2027, a -14% move from its current price of $5.91. DCOY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $5.40 | $5.91 | $6.47 | 0.00% |
| Jul 13 | $5.20 | $5.91 | $6.72 | -0.01% |
| Jul 14 | $5.05 | $5.91 | $6.91 | -0.01% |
| Jul 15 | $4.93 | $5.91 | $7.08 | -0.01% |
| Jul 16 | $4.83 | $5.91 | $7.23 | -0.02% |
| Jul 17 | $4.73 | $5.91 | $7.37 | -0.02% |
| Jul 18 | $4.65 | $5.91 | $7.51 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.65 | $5.91 | $7.51 | -0.02% |
| Week 2 | $4.21 | $5.91 | $8.29 | -0.04% |
| Week 3 | $3.90 | $5.91 | $8.94 | -0.07% |
| Week 4 | $3.66 | $5.90 | $9.53 | -0.09% |
| Week 5 | $3.46 | $5.90 | $10.08 | -0.11% |
| Week 6 | $3.28 | $5.90 | $10.61 | -0.13% |
| Week 7 | $3.13 | $5.90 | $11.11 | -0.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Decoy Therapeutics Inc. is a pre-clinical stage biotechnology company that focuses on peptide conjugate therapeutics through its IMP3ACT platform. This platform leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools.
The company concentrates on developing peptide conjugates for infectious diseases and oncology and is based in Houston, Texas.
It was formerly Salarius Pharmaceuticals, Inc. and changed its name to Decoy Therapeutics Inc. in January 2026. The description reflects its healthcare classification and ongoing work in peptide therapeutics using advanced computational methods.
Decoy Therapeutics Inc. operates in the healthcare sector and is identified by the ticker DCOY in the market. It is described as a pre-clinical stage company pursuing a portfolio of peptide conjugate therapeutics.
Decoy Therapeutics Inc. (DCOY) currently trades at $6.27 per share, has a market cap of $3.33M, and ranks 5419.
The current price sits within a forecast landscape that shows a range of potential prices by year, with notable upside later in the forecast. For 2030, the average price is $7.90 with a recorded ROI of 26.1 and sentiment labeled BULLISH; for 2050, the average price is $17.65 with a ROI of 181.7 and sentiment BULLISH.
The longer-horizon outlook indicates a mix of neutral and bullish periods, with sustained bullish sentiment projected for 2030, 2040, and 2050, alongside earlier years showing more modest or negative returns in some cases.
A major floor 50.5% below — a decisive break under it would weaken the trend.
The nearest floor, 6.8% below — buyers have tended to step in here.
The nearest ceiling, 62.3% above — a clean break opens room to run.
A major ceiling 87.5% above — clearing it would confirm fresh momentum.
Key DCOY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DCOY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.44 | Sell | $6.35 | Sell |
| MA 10 | $6.94 | Sell | $6.56 | Sell |
| MA 20 | $6.48 | Sell | $6.59 | Sell |
| MA 50 | $6.36 | Sell | $6.62 | Sell |
| MA 100 | $6.73 | Sell | $9.55 | Sell |
| MA 200 | $14.48 | Sell | $35.47 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.83 | Neutral |
| Stoch RSI (14) | 16.19 | Buy |
| CCI (20) | -53.95 | Neutral |
| Williams %R (14) | -90.37 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -1.50 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 9.63 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | -0.37 | Sell |
| Ultimate (7,14,28) | 36.89 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 5.77 | Buy |
| ADX (14) | 13.15 | Neutral |
| ATR (14) | 0.61 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 50. SMA50 is $6.35 and SMA200 is $14.70, indicating near-term weakness relative to longer-term momentum.
Support is identified at $5.51 and resistance at $9.59, which frame the near-term trading range alongside the 30-day window.
The thirty-day range spans from a low of $3.40 to a high of $11.55, and annualized volatility is 200%, highlighting substantial price swings over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.41 | $5.91 | $6.82 | 0% | Neutral | |
| $3.68 | $5.07 | $7.56 | -14% | Neutral | |
| $3.05 | $4.46 | $7.09 | -24% | Bearish | |
| $3.90 | $6.01 | $10.02 | +2% | Neutral | |
| $4.61 | $7.46 | $12.96 | +26% | Bullish | |
| $3.76 | $6.36 | $11.43 | +8% | Neutral | |
| $3.97 | $7.00 | $12.97 | +18% | Neutral | |
| $3.54 | $6.49 | $12.36 | +10% | Neutral | |
| $2.56 | $4.89 | $9.55 | -17% | Bearish | |
| $3.60 | $7.15 | $14.29 | +21% | Bullish | |
| $3.43 | $7.63 | $16.75 | +29% | Bullish | |
| $7.49 | $16.64 | $38.28 | +182% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.41 | $5.91 | $6.96 | +0.00% |
| August 2026 | $4.74 | $5.74 | $7.25 | -2.88% |
| September 2026 | $4.79 | $5.89 | $7.59 | +2.67% |
| October 2026 | $4.38 | $5.45 | $7.14 | -7.58% |
| November 2026 | $3.97 | $4.99 | $6.63 | -8.46% |
| December 2026 | $3.99 | $5.06 | $6.82 | +1.48% |
Click any year to see its month-by-month DCOY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DCOY price prediction for 2026 points to an average of $5.91 (low $4.41, high $6.82) — a potential gain of 0% on today's $5.91. Price action looks broadly range-bound.
In 2027, DCOY is projected to trade between $3.68 and $7.56, averaging $5.07 — a potential decline of -14% from today's $5.91. That is -14% versus the projected 2026 average. A consolidation phase looks the most probable path here.
Decoy Therapeutics Inc.'s 2028 outlook centres on $4.46, within a $3.05 to $7.09 range. That is -12% versus the projected 2027 average. That marks a -24% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2029, DCOY could reach as high as $10.02, with a base case around $6.01 and support toward $3.90 — roughly +2% from $5.91. A consolidation phase looks the most probable path here.
Expect DCOY to range from $4.61 to $12.96 through 2030. The $7.46 average target implies a +26% move from current prices. That is up +24% on the projected 2029 average. Momentum favours further upside here.
The DCOY price prediction for 2031 points to an average of $6.36 (low $3.76, high $11.43) — a potential gain of +8% on today's $5.91. A consolidation phase looks the most probable path here.
In 2032, DCOY is projected to trade between $3.97 and $12.97, averaging $7.00 — a potential gain of +18% from today's $5.91. That is up +10% on the projected 2031 average. Price action looks broadly range-bound.
Decoy Therapeutics Inc.'s 2033 outlook centres on $6.49, within a $3.54 to $12.36 range. That is -7% versus the projected 2032 average. That marks a +10% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, DCOY could reach as high as $9.55, with a base case around $4.89 and support toward $2.56 — roughly -17% from $5.91. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect DCOY to range from $3.60 to $14.29 through 2035. The $7.15 average target implies a +21% move from current prices. That is up +46% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DCOY price prediction for 2040 points to an average of $7.63 (low $3.43, high $16.75) — a potential gain of +29% on today's $5.91. Momentum favours further upside here.
In 2050, DCOY is projected to trade between $7.49 and $38.28, averaging $16.64 — a potential gain of +182% from today's $5.91. That is up +118% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DCOY today (≈ 169.204738 DCOY) could be worth
$2,816.34
+$1,816.34 (+182%) by 2050 · US Dollar
Based on the average projected DCOY price of $16.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DCOYwould be worth at today's price.
$1,000 invested in DCOY on Jul 10, 2025 (≈ 7.13165 DCOY) would be worth
$42.15
-$957.85 (-95.8%) today · 0.04× · US Dollar
Based on a DCOY entry price of $140.22 vs. today's $5.91.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.31 | $808.48 | -19.2% |
| 1 month ago | $5.59 | $1,057.25 | +5.7% |
| 3 months ago | $5.84 | $1,011.99 | +1.2% |
| 6 months ago | $9.78 | $604.29 | -39.6% |
| 1 year ago | $140.22 | $42.15 | -95.8% |
| All time (5.0y) ago | $34,884 | $0.17 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DCOY forecast.
Our base-case forecast reaches $12.00 around 2050.
Implied market cap at $12.00: $6.38M
2030 sees an avg price of $7.90 with a ROI of 26.1 and sentiment BULLISH. This year represents a notable move higher from current levels as the forecast contends with ongoing development in the biotech space.
2040 projects an avg price of $8.09 with a ROI of 29.1 and sentiment BULLISH, suggesting continued upside potential despite the volatility in the earlier years.
2050 projects an avg price of $17.65 with a ROI of 181.7 and sentiment BULLISH, with a max forecast of $40.60 and a min of $7.94, indicating substantial long-term upside under the assigned assumptions.
Earlier years show varied performance, including 2027 with avg $5.37 and ROI -14.3, 2028 with avg $4.74 and ROI -24.4, and 2034 with avg $5.18 and ROI -17.3, reflecting periods of downside before the later bullish years.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $7.90 with a ROI of 26.1 and sentiment BULLISH.
Forecasts indicate bullish sentiment in 2030, 2040, and 2050 with meaningful upside (2030 avg $7.90, ROI 26.1; 2040 avg $8.09, ROI 29.1; 2050 avg $17.65, ROI 181.7), but there are earlier years with neutral or negative ROI (for example 2027 ROI -14.3%, 2028 ROI -24.4%), so outcomes are uncertain.
Yes. The 2029 max is $10.65 and the 2030 max is $13.71, indicating potential to exceed $10 in the near term.
Current price is $6.27 and market cap is $3.33M.
For 2050, the average price is $17.65 with a max of $40.60, a min of $7.94, and a ROI of 181.7, with sentiment BULLISH.
Decoy Therapeutics Inc. Community Discussion
0Share your Decoy Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.